发明名称 |
Bone morphogenetic protein 2 (BMP2) variants with reduced BMP antagonist sensitivity |
摘要 |
The present invention is directed to an isolated peptide comprising or consisting of an amino acid sequence with an amino acid identity of at least 90% compared to mature human BMP2 with SEQ ID No. 1, characterized in that said amino acid sequence comprises at least two amino acid substitutions characterized in that a first amino acid substitution occurs at a position corresponding to N59, S88, E94, V99, K101 and/or N102 of SEQ ID No. 1 and to uses thereof. |
申请公布号 |
US8828937(B2) |
申请公布日期 |
2014.09.09 |
申请号 |
US201013255909 |
申请日期 |
2010.03.11 |
申请人 |
Haase Investments UG |
发明人 |
Seemann Petra;Mundlos Stefan;Reissner Carsten;Duda Georg;Zimmer Julia |
分类号 |
A61K38/18;C07K14/435;C07K14/46;C07K14/465;C07K14/51;C12N15/00;C12N15/12;C12N15/63 |
主分类号 |
A61K38/18 |
代理机构 |
Agris & von Natzmer LLP |
代理人 |
von Natzmer Joyce;Agris & von Natzmer LLP |
主权项 |
1. An isolated peptide having BMP-2 activity comprising an amino acid sequence having at least 90% sequence identity with SEQ ID No. 1, wherein said amino acid sequence comprises at least a first and second amino acid substitution, wherein the first amino acid substitution occurs at a position corresponding to N59, E94, V99, K101 or N102 of SEQ ID No. 1. |
地址 |
Alfeld (Leine) DE |